Janet Lafrence Email Address

President and Chief Executive Officers and Chief Financial Officer

SurModics, Inc. is a leading provider of surface modification, drug delivery, and in vitro diagnostic technologies to the healthcare industry.

CFO and COO at StemoniX, Inc. Senior Vice President and Chief Financial Officer at Biothera Pharmaceuticals, Inc. Responsible for finance, HR, IT and investor relations. Vice President, Finance and CFO at Surmodics, Inc. (NASDAQ: SRDX). Member of executive leadership team with responsibility for finance, operations, IT and investor relations. Responsible for operations and manufacturing 2013-2015. CFO at CNS Therapeutics (www.cnstherapeutics.com). Leader of accounting, finance, tax, treasury, government pharma reporting and bank relationship. Significant operational experience in supply chain planning and management, contract negotiations, insurance, risk management and business development. Sold CNS for $100 million in September 2012. As a KPMG partner at KPMG led the Twin Cities Life Sciences practice client base of high energy, entrepreneurial and fast growing businesses. Helped fast growth companies with complex capital needs, including 14 initial public offerings. I have worked with banks to negotiate more favorable terms, performed due diligences for acquisitions and/or to prepare for public offerings, appropriately evaluated deal structures and accounting implications, and help find sources of capital and position companies to grow. My deal structure work has included revenue, buy-versus-lease, key vendor agreements, license and employment contracts, executive compensation arrangements as well as significant SEC reporting experience. Significant board of director experience including board chair and audit committee chair. Specialties: Life Sciences and technology companies, international operations, SEC reporting, corporate governance, strategy, team building and mentoring.